塔克罗利斯患者内变异性与移植中的临床结果之间的关联:一项回顾性队列研究
Hongsheng Chen1,2, Shuang Liu1, Lingling Yu1,2
1Department of Pharmacy, Peking University Third Hospital, Beijing, China.
Translational andrology and urology
|November 13, 2025
概括
塔克罗利马斯水平的患者内变化 (IPV) 与移植患者的急性排斥等不良结果有关. 这种关联在CYP3A5非表达体中特别强,突出显示了在这个群体中需要更密切的监测.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 药物基因组学 药物基因组学
- 移植免疫学 移植免疫学
背景情况:
- 塔克罗利斯的治疗药物监测 (TDM) 通常依赖于最低度,这些度与临床结果的相关性有限.
- 患者内可变性 (IPV),测量血液度波动,是塔克罗利斯治疗的有前途的新标志物.
- 塔克罗利斯IPV对中国移植接受者的影响仍未得到充分探索.
研究的目的:
- 为了调查塔克罗利斯IPV与中国移植接受者的不良结果之间的关联.
- 探索遗传变异,特别是CYP3A5基因型对这种关联的影响.
- 为了确定移植中较差结果的潜在风险因素.
主要方法:
- 一组152名脏移植接受者被追溯研究.
- 在移植后6个月和12个月使用全血度变化系数 (CV) 来量化塔克罗利斯IPV.
- 分析了临床结果,包括移植损失,急性排斥,血清肌水平升高,感染和血液/电解质障碍,并将高和低IPV组进行比较,按CYP3A5基因型分层.
主要成果:
- 高达克罗利斯IPV显着与急性排斥 (HR=3.420),高尿素血和低血有关.
- 在CYP3A5非表达剂中,高IPV与移植损失相关,血清肌氨酸升高,高尿血症,低血症,低磁血症和白血病.
- 在CYP3A5表达者中没有观察到高IPV和不良结果之间的显著关联.
结论:
- 塔克罗利斯IPV是临床结果的重要预测因素,包括急性排斥,在中国的移植接受者.
- 在CYP3A5非表达剂接受者中,高IPV带来更大的不良事件风险,特别是移植损失和功能障碍.
- 临床实践应考虑TACROLIMUS IPV,特别是在CYP3A5非表达剂中,以改善患者管理和结果.
相关概念视频
01:28Kidney Transplant I: Introduction
297
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
297
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
238
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
238
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
181
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
181
01:26Kidney Transplant II: Surgical Procedure
270
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
270
01:16Kidney Transplant III: Nursing Management
286
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
286
01:08Renal Drug Clearance: Comparison Between Renal Excretion Methods
534
Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
534